Several studies of children who were prenatally exposed to elevated levels of polychlorinated biphenyls (PCBs) have suggested linkages between these contaminants and neurodevelopmental effects, including lowered intelligence and behavioral deficits such as inattention and impulsive behavior. [39] [40] [41] [42] [43] [44] Studies have also reported associations between PCB exposure and deficits in learning and memory. 39, 45 Most of these studies found that the effects are associated with exposure in the womb resulting from the mother having eaten food contaminated with PCBs, [46] [47] [48] [49] [50] [51] although some studies have reported relationships between adverse effects and PCB exposure during infancy and childhood. 45, [51] [52] [53] Although there is some inconsistency in the epidemiological literature, several reviews of the literature have found that the overall evidence supports a concern for effects of PCBs on children's neurological development. 52, [54] [55] [56] [57] [58] The Agency for Toxic Substances and Disease Registry has determined that "Substantial data suggest that PCBs play a role in neurobehavioral alterations observed in newborns and young children of women with PCB burdens near background levels." 59 In addition, adverse effects on intelligence and behavior have been found in children of women who were highly exposed to mixtures of PCBs, chlorinated dibenzofurans, and other pollutants prior to conception. [60] [61] [62] [63] A wide variety of other environmental chemicals have been identified as potential concerns for childhood neurological development, but have not been as well studied for these effects as lead, mercury, and PCBs. Concerns for these additional chemicals are based on both laboratory animal studies and human epidemiological research; in most cases, the epidemiological studies are relatively new and the literature is just beginning to develop. Among the chemicals being studied for potential effects on childhood neurological development are organophosphate pesticides, polybrominated diphenyl ether flame retardants (PBDEs), phthalates, bisphenol A (BPA), polycyclic aromatic hydrocarbons (PAHs), arsenic, and perchlorate. Exposure to all of these chemicals is widespread in the United States for both children and adults. 64 Organophosphate pesticides can interfere with the proper function of the nervous system when exposure is sufficiently high. 65 Many children may have low capacity to detoxify organophosphate pesticides through age 7 years. 66 In addition, recent studies have reported an association between prenatal organophosphate exposure and childhood ADHD in a U.S. community with relatively high exposures to organophosphate pesticides, 67 as well as with exposures found within the general U.S. population. 68 Other recent studies have described associations between prenatal organophosphate pesticide exposures and a variety of neurodevelopmental deficits in childhood, including reduced IQ, perceptual reasoning, and memory. [69] [70] [71] Studies of certain PBDEs have found adverse effects on behavior, learning, and memory in laboratory animals. [72] [73] [74] A recent epidemiological study in New York City reported significant associations between children's prenatal exposure to PBDEs and reduced performance on IQ tests and other tests of neurological development in 6-year-old children. 75 Another study in the Netherlands reported significant associations between children's prenatal exposure to PBDEs and reduced performance on some neurodevelopmental tests in 5-and 6-year-old children, while associations with improved performance were observed for other tests. 76 Two studies of a group of New York City children ages 4 to 9 years reported associations between prenatal exposure to certain phthalates and behavioral deficits, including effects on attention, conduct, and social behaviors. 77, 78 Some of the behavioral deficits observed in these studies are similar to those commonly displayed in children with ADHD and conduct disorder. Studies conducted in South Korea of children ages 8 to 11 years reported that children with higher levels of certain phthalate metabolites in their urine were more inattentive and hyperactive, displayed more symptoms of ADHD, and had lower IQ compared with those who had lower levels. 79, 80 The exposure levels in these studies are comparable to typical exposures in the U.S. population.
In 2008, the NTP concluded that there is "some concern" for effects of early-life (including prenatal) BPA exposure on brain development and behavior, based on findings of animal studies conducted at relatively low doses. 81 An epidemiological study conducted in Ohio reported an association between prenatal exposure to BPA and effects on children's behavior (increased hyperactivity and aggression) at age 2 years. 82 Another study of prenatal BPA exposure in New York City reported no association between prenatal BPA exposure and social behavior deficits in testing conducted at ages 7 to 9 years. 78 A series of recent studies conducted in New York City has reported that children of women who were exposed to increased levels of polycyclic aromatic hydrocarbons (PAHs, produced when gasoline and other materials are burned) during pregnancy are more likely to have experienced adverse effects on neurological development (for example, reduced IQ and behavioral problems). 83, 84 Early-life exposure to arsenic has been associated with measures of reduced cognitive function, including lower scores on tests that measure neurobehavioral and intellectual development, in four studies conducted in Asia; however there are some inconsistencies in the findings of these studies. 85 These findings are from countries where arsenic levels in drinking water are generally much higher than in the United States due to high levels of naturally occurring arsenic in groundwater. 86 Perchlorate is a naturally occurring and man-made chemical that has been found in drinking water 87 and foods 88, 89 in the United States. Exposure to elevated levels of perchlorate inhibits iodide uptake into the thyroid gland, thus possibly disrupting the function of the thyroid and potentially leading to a reduction in the production of thyroid hormone. 90, 91 Moderate deficits in maternal thyroid hormone levels during early pregnancy have been linked to reduced childhood IQ scores and other neurodevelopmental effects. [92] [93] [94] Interactions of environmental contaminants and other environmental factors may combine to increase the risk of neurodevelopmental disorders. For example, exposure to lead may have stronger effects on neurodevelopment among children with lower socioeconomic status. 21, 95 A child's brain and nervous system are vulnerable to adverse impacts from pollutants because they go through a long developmental process beginning shortly after conception and continuing through adolescence. 96, 97 This complex developmental process requires the precise coordination of cell growth and movement, and may be disrupted by even short-term exposures to environmental contaminants if they occur at critical stages of development. This disruption can lead to neurodevelopmental deficits that may have an effect on the child's achievements and behavior even when they do not result in a diagnosable disorder.
Attention-Deficit/Hyperactivity Disorder (ADHD)
Attention-deficit/hyperactivity disorder (ADHD) is a disruptive behavior disorder characterized by symptoms of inattention and/or hyperactivity-impulsivity, occurring in several settings and more frequently and severely than is typical for other individuals in the same stage of development. 98 ADHD can make family and peer relationships difficult, diminish academic performance, and reduce vocational achievement.
As the medical profession has developed a greater understanding of ADHD through the years, the name of this condition has changed. The American Psychiatric Association adopted the name "attention deficit disorder" in the early 1980s and revised it to "attentiondeficit/hyperactivity disorder" in 1987. 99 Many children with ADHD have a mix of inattention and hyperactivity/impulsivity behaviors, while some may display primarily hyperactive behavior traits, and others display primarily inattentive traits. It is possible for an individual's primary symptoms of ADHD to change over time. 20 Children with ADHD frequently have other disorders, with parents reporting that about half of children with ADHD have a learning disability and about one in four have a conduct disorder. 2, 100 Other disorders, including anxiety disorders, depression, and learning disabilities, can be expressed with signs and symptoms that resemble those of ADHD. A diagnosis of ADHD requires a certain amount of judgment on the part of a doctor, similar to diagnosis of other mental disorders. Despite the variability among children diagnosed with the disorder and the challenges involved in diagnosis, ADHD has good clinical validity, meaning that impaired children share similarities, exhibit symptoms, respond to treatment, and are recognized with general consistency across clinicians. 20 A great deal of research on ADHD has focused on aspects of brain functioning that are related to the behaviors associated with ADHD. Although this research is not definitive, it has found that children with ADHD generally have trouble with certain skills involved in problem-solving (referred to collectively as executive function). These skills include working memory (keeping information in mind while briefly doing something else), planning (organizing a sequence of activities to complete a task), response inhibition (suppressing immediate responses when they are inappropriate), and cognitive flexibility (changing an approach when a situation changes). Children with ADHD also generally have problems in maintaining sustained attention to a task (referred to as vigilance), and/or maintaining readiness to respond to new information (referred to as alertness). 20, 101, 102 While uncertainties remain, findings to date indicate that ADHD is caused by combinations of genetic and environmental factors. 20, [103] [104] [105] [106] Much of the research on environmental factors has focused on the fetal environment. Maternal smoking during pregnancy has been associated with increased risk of ADHD in the child in numerous studies, however, this continues to be an active area of research as scientists consider whether other factors related to smoking (e.g., genetic factors, maternal mental health, stress, alcohol use, and low birth weight) may be responsible for associations attributed to smoking. 17, 19, 107 Findings regarding ADHD and maternal consumption of alcohol during pregnancy are considered more limited and inconsistent. 19, 20 Preterm birth and low birth weight have also been found to increase the likelihood that a child will have ADHD. 16, 18, 20 Psychosocial adversity (representing factors such as low socioeconomic status and in-home conflict) in childhood may also play a role in ADHD. 108 The potential role of environmental contaminants in contributing to ADHD, either alone or in conjunction with certain genetic susceptibilities or other environmental factors, is becoming better understood as a growing number of studies look explicitly at the relationship between ADHD and exposures to environmental contaminants.
Among environmental contaminants known or suspected to be developmental neurotoxicants, lead has the most extensive evidence of a potential contribution to ADHD. A number of recent epidemiological studies (all published since 2006, with data gathered beginning in 1999 or more recently) conducted in the United States and Asia have reported relationships between increased levels of lead in a child's blood and increased likelihood of ADHD. 55, [109] [110] [111] [112] [113] [114] [115] In most of these studies, blood lead levels were comparable to levels observed currently in the United States. The potential contribution of childhood lead exposure to the risk of ADHD may be amplified in children of women who smoked cigarettes during pregnancy. 110 In addition, several studies have reported relationships between blood lead levels and the aspects of brain functioning that are most affected in children with ADHD, including sustained attention, alertness, and problem-solving skills (executive functions, specifically cognitive flexibility, working memory, planning, and response inhibition). 22, 44, 55, [116] [117] [118] [119] Similar results have been observed in laboratory animal studies. 55, 96, [120] [121] [122] The NTP has concluded that childhood lead exposure is "associated with increased diagnosis of attention-related behavioral problems." 22 Although no studies evaluating a potential association between PCBs and ADHD itself have been published, a study in Massachusetts reported a relationship between levels of PCBs measured in cord blood and increased ADHD-like behaviors observed by teachers in children at ages 7 to 11 years. PCB levels in this study were generally lower than those measured in other epidemiological studies of PCBs and childhood neurological development. 40 Other research findings also suggest that PCBs may play a role in contributing to ADHD. Several studies in U.S. and European populations, most having elevated exposure to PCBs through the diet, have found generally consistent associations with aspects of brain function that are most affected in children with ADHD, including alertness and problem-solving skills (executive functions, specifically response inhibition, working memory, cognitive flexibility, and planning). 54, 55 Studies in laboratory animals have similar findings regarding the mental functions affected by PCB exposure. 55, 96 Studies of other environmental chemicals reporting associations with ADHD or related outcomes have been published in recent years, but findings tend to be much more limited than for lead and PCBs. Findings for phthalates and organophosphate pesticides were noted above. In addition, three studies have reported associations between ADHD or impulsivity and concentrations of certain perfluorinated chemicals measured in the blood of children. [123] [124] [125] Studies of mercury have produced generally mixed findings of associations with ADHD or related symptoms and mental functions. 29, 111, 118, [126] [127] [128] 
Learning Disability
Learning disability (or learning disorder) is a general term for a neurological disorder that affects the way in which a child's brain can receive, process, retain, and respond to information. A child with a learning disability may have trouble learning and using certain skills, including reading, writing, listening, speaking, reasoning, and doing math, although learning disabilities vary from child to child. Children with learning disabilities usually have average or aboveaverage intelligence, but there are differences in the way their brains process information. 129 As with many other neurodevelopmental disorders, the causes of learning disabilities are not well understood. Often learning disabilities run in the family, suggesting that heredity may play a role in their development. Problems during pregnancy and birth, such as drug or alcohol use during pregnancy, low birth weight, lack of oxygen, or premature or prolonged labor, may also lead to learning disabilities. 130 As is the case with other neurodevelopmental outcomes, there are generally many more studies of lead exposure that are relevant to learning disabilities than for other environmental contaminants. Several studies have found associations between lead exposure and learning disabilities or reduced classroom performance that are independent of IQ. 119, 120, [131] [132] [133] Exposures to lead have been associated with impaired memory and difficulties or impairments in rule learning, following directions, planning, verbal abilities, speech processing, and classroom performance in children. 22, 119, 131, [134] [135] [136] [137] Other findings that may indicate contributions from environmental contaminants to learning disabilities include a study that found associations of both maternal smoking during pregnancy and childhood exposure to environmental tobacco smoke with parent report of a child with a learning disability diagnosis; 138 associations of prenatal mercury exposure with dysfunctions in children's language abilities and memory, 29, 30 and associations of prenatal PCB exposure with poorer concentration and memory deficits compared with unexposed children. 39, 45 
Autism Spectrum Disorders
Autism spectrum disorders (ASDs) are a group of developmental disabilities defined by significant social, communication, and behavioral impairments. The term "spectrum disorders" refers to the fact that although people with ASDs share some common symptoms, ASDs affect different people in different ways, with some experiencing very mild symptoms and others experiencing severe symptoms. ASDs encompass autistic disorder and the generally less severe forms, Asperger's syndrome and pervasive developmental disorder-not otherwise specified (PDD-NOS). Children with ASDs may lack interest in other people, have trouble showing or talking about feelings, and avoid or resist physical contact. A range of communication problems are seen in children with ASDs: some speak very well, while many children with an ASD do not speak at all. Another hallmark characteristic of ASDs is the demonstration of restrictive or repetitive interests or behaviors, such as lining up toys, flapping hands, rocking his or her body, or spinning in circles. 139 To date, no single risk factor sufficient to cause ASD has been identified; rather each case is likely to be caused by the combination of multiple genetic and environmental risk factors. [140] [141] [142] Several ASD research findings and hypotheses may imply an important role for environmental contaminants. First, there has been a sharp upward trend in reported prevalence that cannot be fully explained by factors such as younger ages at diagnosis, migration patterns, changes in diagnostic criteria, inclusion of milder cases, or increased parental age. 8, 9, [143] [144] [145] [146] Also, the neurological signaling systems that are impaired in children with ASDs can be affected by certain environmental chemicals. For example, several pesticides are known to interfere with acetylcholine (Ach) and γ-aminobutyric acid (GABA) neurotransmission, chemical messenger systems that have been altered in certain subsets of autistic individuals. 147 Some studies have reported associations between certain pharmaceuticals taken by pregnant women and increased incidence of autism, which may suggest that there are biological pathways by which other chemical exposures during pregnancy could increase the risk of autism. 148 Furthermore, some of the identified genetic risk factors for autism are de novo mutations, meaning that the genetic defect is not present in either of the parents' genes, yet can be found in the genes of the child when a new genetic mutation forms in a parent's germ cells (egg or sperm), potentially from exposure to contaminants. 140, 142, 149, 150 Many environmental contaminants have been identified as agents capable of causing mutations in DNA, by leading to oxidative DNA damage and by inhibiting the body's normal ability to repair DNA damage. 151 Some children with autism have been shown to display markers of increased oxidative stress, which may strengthen this line of reasoning. [152] [153] [154] Many studies have linked increasing paternal and maternal age with increased risk of ASDs. 144, 146, [155] [156] [157] The role of parental age in increased autism risk might be explained by evidence that shows advanced parental age can contribute significantly to the frequency of de novo mutations in a parent's germ cells. 151, 158, 159 Advanced parental age signifies a longer period of time when environmental exposures may act on germ cells and cause DNA damage and de novo mutations. Finally, a recent study concluded that the role of genetic factors in ASDs has been overestimated, and that environmental factors play a greater role than genetic factors in contributing to autism. 141 This study did not evaluate the role of any particular environmental factors, and in this context "environmental factors" are defined broadly to include any influence that is not genetic.
Studies, limited in number and often limited in research design, have examined the possible role that certain environmental contaminants may play in the development of ASDs. A number of these studies have focused on mercury exposures. Earlier studies reported higher levels of mercury in the blood, baby teeth, and urine of children with ASDs compared with control children; [160] [161] [162] however, another more recent study reported no difference in the blood mercury levels of children with autism and typically developing children. 163 Proximity to industrial and power plant sources of environmental mercury was reported to be associated with increased autism prevalence in a study conducted in Texas. 164 Thimerosal is a mercury-containing preservative that is used in some vaccines to prevent contamination and growth of harmful bacteria in vaccine vials. Since 2001, thimerosal has not been used in routinely administered childhood vaccines, with the exception of some influenza vaccines. 165 The Institute of Medicine has rejected the hypothesis of a causal relationship between thimerosal-containing vaccines and autism. 166 Some studies have also considered air pollutants as possible contributors to autism. A study conducted in the San Francisco Bay Area reported an association between the amount of certain airborne pollutants at a child's place of birth (mercury, cadmium, nickel, trichloroethylene, and vinyl chloride) and the risk for autism, but a similar study in North Carolina and West Virginia did not find such a relationship. 167, 168 Another study in California reported that mothers who lived near a freeway at the time of delivery were more likely to have children diagnosed with autism, suggesting that exposure to traffic-related air pollutants may play a role in contributing to ASDs. 169 Finally, a study in Sweden reported an increased risk of ASDs in children born to families living in homes with polyvinyl chloride (PVC) flooring, which is a source of certain phthalates in indoor environments. 170 
Intellectual Disability (Mental Retardation)
The most commonly used definitions of intellectual disability (also referred to as mental retardation) emphasize subaverage intellectual functioning before the age of 18, usually defined as an IQ less than 70 and impairments in life skills such as communication, self-care, home living, and social or interpersonal skills. Different severity categories, ranging from mild to severe retardation, are defined on the basis of IQ scores. 171, 172 "Intellectual disability" is used as the preferred term for this condition in the disabilities sector, but the term "mental retardation" continues to be used in the contexts of law and public policy when designating eligibility for state and federal programs. 171 Researchers have identified some causes of intellectual disability, including genetic disorders, traumatic injuries, and prenatal events such as maternal infection or exposure to alcohol. 172, 173 However, the causes of intellectual disability are unknown in 30-50% of all cases. 173 The causes are more frequently identified for cases of severe retardation (IQ less than 50), whereas the cause of mild retardation (IQ between 50 and 70) is unknown in more than 75% of cases. 174, 175 Exposures to environmental contaminants could be a contributing factor to the cases of mild retardation where the cause is unknown. Exposure to high levels of lead and mercury have been associated with intellectual disability. 23, [176] [177] [178] Furthermore, lead, mercury, and PCBs all have been found to have adverse effects on intelligence and cognitive functioning in children, 22, 26, 43, 52, 179 and recent studies have reported associations of a number of other environmental contaminants with childhood IQ deficits, including organophosphate pesticides, [69] [70] [71] PBDEs, 75 phthalates, 79 and PAHs. 83, 180 Exposure to environmental contaminants that reduce IQ has the potential to increase the proportion of the population with IQ less than 70, thus increasing the incidence of intellectual disability in an exposed population. [181] [182] [183] 
Indicators in this Section
The four indicators that follow provide the best nationally representative data available on the prevalence of neurodevelopmental disorders among U.S. 
Data Presented in the Indicators
The following indicators display the prevalence of ADHD, learning disabilities, autism, and intellectual disability among U.S. children, for the years 1997-2017. Diagnosing neurodevelopmental disorders in young children can be difficult: many affected children may not receive a diagnosis until they enter preschool or kindergarten. For this reason, the indicators here show children ages 5 to 17 years. Where data are sufficiently reliable, the indicators provide separate prevalence estimates for boys and girls.
Although the NHIS provides national-level data on the prevalence of neurodevelopmental disorders over a span of many years, NHIS data could underestimate the prevalence of neurodevelopmental disorders. Reasons for underestimation may include late identification of affected children and the exclusion of institutionalized children from the NHIS survey population. A diagnosis of a neurodevelopmental disorder depends not only on the presence of particular symptoms and behaviors in a child, but on concerns being raised by a parent or teacher about the child's behavior, as well as the child's access to a doctor and the accuracy of the doctor's diagnosis. Further, the NHIS relies on parents reporting that their child has been diagnosed with a neurodevelopmental disorder, and the accuracy of parental responses could be affected by cultural and other factors.
Long-term trends in these conditions are difficult to detect with certainty due to a lack of data to track prevalence over many years, as well as changes in awareness and diagnostic criteria, which could explain at least part of the observed increasing trends. [184] [185] [186] The NHIS questions also do not assess whether a child currently has a disorder; instead, they provide data on whether a child has ever been diagnosed with a disorder, regardless of their current status.
Survey responses for learning disabilities may be more uncertain than for the other three disorders presented. Whereas survey respondents are asked whether the child has been diagnosed with ADHD, autism, or intellectual disability (mental retardation) by a health professional, for learning disabilities an affirmative response may also include a school representative. It is possible that some parents may respond "yes" to the question regarding learning disabilities based on informal comments made at school, rather than a formal evaluation to determine whether the child has any specific learning disability; similarly, they may give a "yes" answer for children with diagnosed disorders that are not learning disabilities. For example, parents of children with intellectual disability might also respond "yes" to the learning disability question, thinking that any learning problems may apply, even though intellectual disability and learning disabilities are distinct conditions. 2 Up to 2013, autism was the only autism spectrum disorder (ASD) referred to in the survey, and it is not clear how parents of children with other ASDs, i.e., Asperger's syndrome and PDD-NOS, may have responded. The estimates shown by Indicator H8 for the years 1997 to 2013 could been diagnosed with "autism, Asperger's disorder, pervasive developmental disorder, or autism spectrum disorder." represent underestimates of ASD prevalence if parents of children with Asperger's syndrome and PDD-NOS did not answer yes to the NHIS questions about autism.
In addition to the data shown in the indicator graphs, supplemental tables provide information regarding the prevalence of neurodevelopmental disorders for different age groups and prevalence by race/ethnicity, sex, and family income. These comparisons use the most current four years of data available. The data from four years are combined to increase the statistical reliability of the estimates for each race/ethnicity, sex, and family income group. The tables include prevalence estimates for the following race/ethnicity groups: White non-Hispanic, Black non-Hispanic, Asian non-Hispanic, Hispanic, and "All Other Races." The "All Others Races" category includes all other races not specified, together with those individuals who report more than one race. The limits of the sample design and sample size often prevent statistically reliable estimates for smaller race/ethnicity groups. The data are also tabulated for three income groups: all incomes, income below the poverty level, and greater than or equal to the poverty level.
Please see the Introduction to the Health section for discussion of statistical significance testing applied to these indicators.
Other Estimates of ADHD and Autism Prevalence
In addition to NHIS, other NCHS studies provide data on prevalence of ADHD and ASDs among children. The National Survey of Children's Health (NSCH), conducted in 2003 by NCHS, found that 7.8% of children ages 4 to 17 years had ever been diagnosed with ADHD. The same survey, when conducted again in 2007, found that 9.5% of children ages 4 to 17 years had ever been diagnosed with ADHD. 7 Both estimates are somewhat higher than the ADHD prevalence estimates from the NHIS for those years. The 2007 NSCH also estimates that 7.2% of children ages 4 to 17 years currently have ADHD. The 2007 NSCH also provides information at the state level: North Carolina had the highest rate, with 15.6% of children ages 4 to 17 years having ever been diagnosed with ADHD; the rate was lowest in Nevada, at 5.6%. 7 In 2002 and 2006, the Centers for Disease Control and Prevention performed thorough data gathering in selected areas to examine the prevalence of ASDs in eight-year-old children. The ASD prevalence estimate for 2002 was 0.66%, or 1 in 152 eight-year-old children, and the estimate for 2006 was 0.9%, or 1 in 110 eight-year-old children. 8, 187 The 2007 NSCH also provides an estimate of 1.1% of children ages 3 to 17 years reported to have ASDs, or about 1 in 90. 188  From 1997 to 2017, the proportion of children ages 5 to 17 years reported to have ever been diagnosed with attention-deficit/hyperactivity disorder (ADHD) increased from 6.3% in 1993 to 10.7% in 2017.
Data Tables for this Topic
 The increasing trend was statistically significant for children overall, and for both boys and girls considered separately.
 For the years 2014-2017, the percentage of boys reported to have ADHD (14.6%) was higher than the rate for girls (6.5%). This difference was statistically significant. (See Table  H6a  The prevalence of learning disability reported for Hispanic children and for Asian non-Hispanic children were lower than for the remaining race/ethnicity groups, and these differences were statistically significant. The difference in prevalence between Hispanic and Asian non-Hispanic children was also statistically significant.
 For the years 2014-2017, the percentage of children reported to have a learning disability was higher for children living below the poverty level (12.8%) compared with those living at or above the poverty level (7.3%), a statistically significant difference. (See Table H7b .)
America's Children and the Environment | Third Edition, Updated August 2019 * The estimate should be interpreted with caution because the standard error of the estimate is relatively large: the relative standard error, RSE, is at least 30% but is less than 40% (RSE = standard error divided by the estimate).
 The percentage of children ages 5 to 17 years reported to have ever been diagnosed with autism rose from 0.1% in 1997 to 1.2% in 2013. This increasing trend was statistically significant.
 Between 2014 and 2017, the rates of reported autism ranged from 2.3% to 2.8%. The higher reported percentages in these years compared with prior years might be due in part to the recent broadening of the definition of autism used in the survey question, as noted in the above "Data characterization" box.
 For the years 2014-2017, the rate of reported autism was about four times higher in boys than in girls, 3.8% and 1.1%, respectively. This difference was statistically significant. (See Table H8a .)
 The reported prevalence of autism varies by race/ethnicity. The highest prevalence of autism is for children of "All Other Races" (3.0%) and White non-Hispanic children (2.9%). Autism prevalence was lower among Black non-Hispanic children (2.2%), Hispanic children (1.8%), and Asian non-Hispanic children (1.6%). (See Table H8b .)
 The prevalence of autism for both White non-Hispanic children and children of "All
Other Races" was statistically significantly different from the prevalence for both Asian non-Hispanic children and Hispanic children.
 For the years 2014-2017, the prevalence of autism was similar for children living below the poverty level and those living at or above the poverty level. (See Table H8b .)
Data characterization
-Data for this indicator are obtained from an ongoing annual survey conducted by the National Center for Health Statistics. -Survey data are representative of the U.S. civilian noninstitutionalized population.
-A parent or other knowledgeable adult in each sampled household is asked questions regarding the child's health status, including if they have ever been told the child has autism. From 2011 to 2013, the term "autism" in the question was revised to "autism/autism spectrum disorder." Starting in 2014, the term "autism" in the question was revised to "autism, Asperger's disorder, pervasive developmental disorder, or autism spectrum disorder."
Data Tables for this Topic
Data characterization -Data for this indicator are obtained from an ongoing annual survey conducted by the National Center for Health Statistics. -Survey data are representative of the U.S. civilian noninstitutionalized population.
-A parent or other knowledgeable adult in each sampled household is asked questions regarding the child's health status, including if they have ever been told the child has mental retardation. -A parent or other knowledgeable adult in each sampled household is asked questions regarding the child's health status, including if they have ever been told the child has mental retardation. Starting in 2011, the term "mental retardation" in the question was revised to "an intellectual disability, otherwise known as mental retardation."  In 2017, 1.0% of children ages 5 to 17 years were reported to have ever been diagnosed with intellectual disability (mental retardation). This percentage fluctuated between 0.6% and 0.9% from 1997 to 2010, and was between 1.0% and 1.5% from 2011 to 2017.
 The higher reported percentages in 2011 to 2017 compared with prior years might be in part due to the revision of the survey question wording, as noted in the above "Data characterization" box.
 In 2014-2017, the percentage of boys reported to have intellectual disability (1.5%) was higher than for girls (0.9%). This difference was statistically significant. (See Table H9a .)
 In 2014-2017, the reported prevalence of intellectual disability was lowest for Asian non-Hispanic children (0.5%) and was between 1.2% and 1.4% for the other race/ethnicity groups. The differences between Asian non-Hispanic children and children of other race/ethnicity groups were statistically significant. (See Table H9b .)
 In 2014-2017, 2.0% of children from families with incomes below the poverty level were reported to have intellectual disability, compared with 1.0% of children from families at or above the poverty level, a statistically significant difference. (See Table H9b .)
